In attempts to provide valved conduits to patients undergoing, for example, the Norwood Procedure, some institutions have created hybrid valved conduits by attaching a homograft valve and to a synthetic conduit. While this approach may offer some benefit over a valve-less conduit, homograft valves impart a number of other problems, including calcification, immune rejection, and occasional perforation of valve leaflets, among others. ePTFE valved conduits have been shown to greatly resist these issues, which has led to improved results compared to homograft for similar pediatric cardiac surgical procedures where larger-diameter valved conduits are used. Following this precedent, a properly-functioning valved small-diameter RV-PA conduit would likely maintain the improved short-term results of the valveless RV-PA conduits while improving mid-term and long-term results as well. The techniques and design principles used to create such a device may provide utility for additional applications as well, such as valved conduits or valved stents for other anatomical positions or other pathologies.
Various embodiments are directed to valves including: a conduit having an inner conduit surface and an outer conduit surface; and a valve structure comprising one or more leaflet, each leaflet having an outer sinus edge, an inner sinus edge, an open sinus edge and a fan, attached to the inner surface of the conduit at the outer sinus edge and inner sinus edge, wherein the open sinus edge is suspended below the inner surface of the conduit by a depth creating a sinus between the leaflet and the inner conduit surface. In some embodiments, each leaflet has a substantially triangular shape. In certain embodiments, each open sinus edge has a width that is less than the circumference of the conduit between fixture points of the leaflet to the conduit, and in particular embodiments, the outer sinus edge and the inner sinus edge may be attached to the conduit by a fluid impervious connection selected from the group consisting of suturing, welding, fusion, applying an adhesive, and combinations thereof. In various embodiments, the conduit and valve structure may each individually be composed of any biocompatible and hemocompatible polymer, and in such embodiments, the biocompatible and hemocompatible polymer may be a fluoropolymer such as, but not limited to, polytetrafluoroethylene, expanded polytetrafluoroethelyne, polyester, polyethylene terephthalate, polydimethylsiloxane, polyurethane, and combinations thereof. In particular embodiments, the biocompatible and hemocompatible polymer may be a polymer coated with a bioactive coating or surface-modified to include a bioactive material, and in such embodiments, the bioactive material may be an anti-coagulant coating, coumadin, heparin, a heparin derivative, a Factor Xa inhibitor, a direct thrombin inhibitor, hementin, sintered porous titanium microspheres, carbon coating, and combinations thereof. In some embodiments, each leaflet may have a ratio of width of the leaflet to a portion of a circumference of the conduit between fixing points of about 0.63 to about 1, and in certain embodiments, each leaflet may have a ratio of width of the leaflet to conduit diameter of about 0.9 to about 1.7. In some embodiments, the valve may further include a stent attached to an outer surface of the conduit.
Other embodiments are directed to stents including: a stent having an inner stent surface and an outer stent surface; and a valve structure comprising one or more leaflet, each leaflet having an outer sinus edge, an inner sinus edge, an open sinus edge and a fan, attached to the inner surface of the conduit at the outer sinus edge and inner sinus edge, wherein the open sinus edge is suspended below the inner surface of the conduit by a depth creating a sinus between the leaflet and the inner conduit surface. In some embodiments, each leaflet has a substantially triangular shape. In certain embodiments, each open sinus edge has a width that is less than the circumference of the conduit between fixture points of the leaflet to the conduit, and in particular embodiments, the outer sinus edge and the inner sinus edge may be attached to the conduit by a fluid impervious connection such as, but not limited to, suturing, welding, fusion, applying an adhesive, and combinations thereof. In various embodiments, the conduit and valve structure may each individually be composed of any biocompatible and hemocompatible polymer, and in such embodiments, the biocompatible and hemocompatible polymer may be a fluoropolymer such as, but not limited to, polytetrafluoroethylene, expanded polytetrafluoroethelyne, polyester, polyethylene terephthalate, polydimethylsiloxane, polyurethane, and combinations thereof. In particular embodiments, the biocompatible and hemocompatible polymer may be a polymer coated with a bioactive coating or surface-modified to include a bioactive material, and in such embodiments, the bioactive material may be an anti-coagulant coating, coumadin, heparin, a heparin derivative, a Factor Xa inhibitor, a direct thrombin inhibitor, hementin, sintered porous titanium microspheres, carbon coating, and combinations thereof. In some embodiments, each leaflet may have a ratio of width of the leaflet to a portion of a circumference of the conduit between fixing points of about 0.63 to about 1, and in certain embodiments, each leaflet may have a ratio of width of the leaflet to conduit diameter of about 0.9 to about 1.7. In some embodiments, the stent may further include conduit disposed between the stent and the valve.
Further embodiments, are directed to methods for making a valve including the steps of: inverting a conduit having an inner surface and an outer surface such that the inner surface is outward facing; bending a portion of the conduit along a longitudinal axis to create a tapered dimple; attaching a valve structure comprising one or more leaflet, each leaflet having an outer sinus edge, an inner sinus edge, an open sinus edge and a fan, by attaching the outer sinus edge and the inner sinus edge to the inner surface of the conduit at the tapered dimple; and reverting the conduit, thereby producing a valve structure on the inner surface of the conduit wherein the open sinus edge is suspended below the inner surface of the conduit by a depth creating a sinus between the leaflet and the inner conduit surface. In some embodiments, bending can be carried out using a fixture stencil. In certain embodiments, bending may further include mechanically deforming the conduit, heating the conduit, vacuum deforming the conduit, or combinations thereof.
Yet other embodiments include fixing stencils including: a handle; a stencil head attached at an end of the handle, the stencil head having a triangular flat surface having a base, a first outer edge, a second outer edge, and a tip, and a triangular curved surface opposite the triangular flat surface, the triangular curved surface being tapered laterally from a longitudinal axis extending from the handle to first outer edge and from the longitudinal axis to the second outer edge and being curved from the base to the tip creating a substantially tetrahedral shape stencil head extending away from the handle. In some embodiments, the fixing stencil may further include holes or slots along the first outer edge and the second outer edge, in other embodiments, the stencil head may be pierceable or locally destructible along the first outer edge and second outer edge.
Before the invention is described, it is to be understood that this invention is not limited to the particular systems, methodologies or protocols described, as these may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present disclosure.
Various embodiments are directed to valved conduits having leaflets that do not contact the wall of the conduit in open position (
The gap area 202 between the inner surface 21 of the conduit 20 and the leaflet can be created by any means. For example, in some embodiments, the width W of the leaflets 201 may be shorter than the length of conduit between fixture points, Df. This arrangement is illustrated in
Each leaflet 401a, 401b of such leaflet structures may include an outer sinus edge 402a, 402b, an inner sinus edge 403a, 403b, and an open sinus edge 404a, 404b. In embodiments in which the leaflet structure includes two or more leaflets, the open sinus edge 404a, 404b of each leaflet 401a, 401b may by coextensive as illustrated in
In some embodiments, the leaflet structure 44 may further include a fan 410, having a fan edge 411, extending beyond the open sinus edge 404 away from the outer sinus edge 401 and inner sinus edge 402. The fan 410 may allow the leaflets of the valve to contact one another or overlap when the valve is in the closed position (see
This arrangement is further illustrated in
Some embodiments are directed to a stent 950 containing a valve 900 such as those described above. Although
A valve having leaflets as described and discussed above may reduce the contact of the leaflets and, in some embodiments, fans attached to the open edge, with the inner surface of the conduit when the valve is in open configuration. Reduced contact with the inner surface of the conduit decreases the likelihood that the valve will stick in open configuration and may also reduce wear on the leaflet over many cycles. Thus, the valves of various embodiments may provide improved long term use when implanted as part of a medical device. For example, in some embodiments, the valves described above may be used as a shunt for connecting of the right ventricle to the pulmonary artery following a Norwood operation, as frequently performed for the treatment of single-functional-ventricle-disorders such as Hypoplastic Left Heart Syndrome. In other embodiments, the valves described above may be used for the correction or reconstruction of the right ventricle outflow tract (RVOT) for congenital heart disorders such as tetralogy of Fallot, Truncus Arterious, DextroTransposition of the Great Arteries, Pulmonary Atresia of Intact Ventricular Septum, or Aortic Valvular Disease. In still other embodiments, the valves described above may be incorporated into a stent and deployed as artificial valves in adult and pediatric patients.
The conduit 10, 20, 30, 40, 50, 60, 70 and stents 90 of various embodiments, and the valve structure 100, 200, 300, 400, 500, 600, 700, 900 may be composed of any biocompatible and hemocompatible polymer. For example, in some embodiments, biocompatible and hemocompatible polymer may be a fluoropolymer, and in certain embodiments, the biocompatible and hemocompatible polymer may be polytetrafluoroethylene, expanded polytetrafluoroethelyne, polyester, polyethylene terephthalate, polydimethylsiloxane, polyurethane, and combinations thereof. In some embodiments, the biocompatible and hemocompatible polymer may be a polymer coated with a bioactive coating, or in other embodiments, the biocompatible and hemocompatible polymer may be surface-modified to include a bioactive material. The bioactive coating or bioactive material may be an anti-coagulant coating or material that promotes biocompatibility such as, for example, coumadin, heparin, a heparin derivative, a Factor Xa inhibitor, a direct thrombin inhibitor, hementin, sintered porous titanium microspheres, a carbon coating, or combinations thereof.
The conduit 10, 20, 30, 40, 50, 60, 70, 90 may generally be flexible, and the size of the conduit of various embodiments may vary depending on the intended use of the valve. For example, in some embodiments, the conduit 10, 20, 30, 40, 50, 60, 70, 90 may have a diameter to of about 40 mm to about 15 mm, 25 mm to about 2 mm, about 20 mm to about 2 mm, about 15 mm to about 2 mm, about 10 mm to about 2 mm, about 8 mm to about 3 mm, about 5 mm to about 3 mm, or any range or individual diameter encompassed by these example ranges. In other embodiments, the conduit 10, 20, 30, 40, 50, 60, 70, 90 may have a diameter of about 40 mm to about 15 mm, 25 mm to about 5 mm, about 20 mm to about 8 mm, about 15 mm to about 10 mm, or any range or individual diameter encompassed by these example ranges. The conduit 10, 20, 30, 40, 50, 60, 70, 90 may have a various thicknesses depending on the intended use. For example, in various embodiments, the conduit may have a thickness of about 0.05 mm to 0.5 mm, 0.5 mm to about 2.0 mm, about 0.5 mm to about 1.5 mm, or any range or individual thickness encompassed by these example ranges.
The valve structure 100, 200, 300, 400, 500, 600, 700, 900 may have a thickness of about 0.05 mm to about 0.3 mm in various embodiments, and this thickness may vary within the valve structure. For example, in some embodiments, the leaflet may have a greater thickness than a fan or a fan may have a greater thickness than the leaflet. The thickness of such valve structures may be selected to provide sufficient flexibility to allow the valve to obtain the open and closed configurations under the pressure of the flow of fluid through the conduit. The dimensions of each leaflet 101, 201, 301, 401, 501, 601, 701, 901 of the valve structure 100, 200, 300, 400, 500, 600, 700, 901 may vary depending on the diameter of the conduit 10, 20, 30, 40, 50, 60, 70, 90 and the number of leaflets 101, 201, 301, 401, 501, 601, 701 making up the valve structure 100, 200, 300, 400, 500, 600, 700, 901. For example with reference to
In various such embodiments, the width, W, of the leaflet 701 may be about 1 mm to about 10 mm, about 2 mm to about 7 mm, about 2 mm to about 5 mm, about 20 mm to about 40 mm, about 10 mm to about 30 mm, or any individual width or range encompassed by these example widths. The length, B, of the leaflet 701 may be about 5 mm to about 40 mm, about 5 mm to about 30 mm, about 8 mm to about 25 mm, about 10 mm to about 20 mm, or any individual length, B, or range encompassed by these example lengths. The length of the inner sinus edge 703 about outer sinus edge 704 may each, individually, be about 5 mm to about 45 mm, about 5 mm to about 35 mm, about 8 mm to about 30 mm, about 10 mm to about 20 mm, or any individual length or range encompassed by these example lengths. In some embodiments, multiple leaflet valves may have no commissure, and in other embodiments, multiple leaflet valves may have a commissure having a length of about 0.05 mm, about 0.1 mm, about 0.2 mm, about 0.3 mm, about 0.5 mm, about 0.8 mm, about 1.0 mm, about 1.5 mm, about 2.0 mm, about 4.0 mm, about 6.0 mm, about 8.0 mm, about 10.0 mm, about 12.0 mm, or any individual length encompassed by these example lengths.
Although
The valves 100, 200, 300, 400, 500, 600, 700, 900 described above are not limited to a particular utility. For example, in some embodiments, the valves described above 100, 200, 300, 400, 500, 600, 700, 900 can be used as heart valves 1 for use in cardiac, coronary or vascular procedures, which may be composed of one or more heart valve leaflets. The term may encompass, as non-limiting examples, a heart valve single leaflet structure having a single heart valve leaflet, or a heart valve multi-leaflet structure having more than one heart valve leaflet. Each heart valve leaflet may include a sinus edge, a fan edge, a sinus structure, and a fan structure, and additional structural components such as, without limitation, a conduit (which may be tube-like, stent-like, or multi-layered such as a tube within a stent) and one or more conduit sinus structures. The term may encompass a single leaflet valve structure having a valve single leaflet structure, or a multi-leaflet valve structure composed of either multiple valve single leaflet structures or a valve multi-leaflet structure.
Various embodiments are directed to a fixing stencil 840. In some embodiments as illustrated in
The handle 842 of various embodiments may be any means for manipulating and holding the fixing stencil 840 in place while the valve is attached to the conduit. For example, in some embodiments, the handle may be sized and shaped to be gripped by a human hand. In other embodiments, the handle may be include one or more tabs or wings sized and shaped for holding the fixing stencil to the conduit and valve using surgical tools, claps, vice grips, or other tools.
The size of the stencil head 841 may vary depending on the size and shape of the valve to 8 that will be produced using the fixing stencil 840. In general, the length, Bs, from the base 844, extending from the handle, to the tip 845, of the stencil head 841 may be substantially the same length, B, as the leaflet 801. The variable width, WSL, of the substantially triangular flat surface may substantially correspond to the variable width of the triangular leaflet and the variable depth, DSL, of the triangular curved surface 884 may substantially corresponding to the depth of the sinus 830. Thus, the stencil head may be configured to have substantially the same shape and volume as the sinus 830 created between the leaflet 801 and the portion of the conduit 80 making up the tapered dimple 85.
In various embodiments, the width, WSL, of the stencil head 841 may be about 1 mm to about 10 mm, about 2 mm to about 7 mm, about 2 mm to about 5 mm, about 20 mm to about 40 mm, about 10 mm to about 30 mm, or any individual width or range encompassed by these example widths. The length, BS, of the stencil head 841 may be about 5 mm to about 40 mm, about 5 mm to about 30 mm, about 8 mm to about 25 mm, about 10 mm to about 20 mm, or any individual length or range encompassed by these example lengths. The length of the first outer edge 845 and second outer edge 846 may each, individually, be about 5 mm to about 45 mm, about 5 mm to about 35 mm, about 8 mm to about 30 mm, about 10 mm to about 20 mm, or any individual length or range encompassed by these example lengths. The depth, DSL, of the stencil head 841 at the base 844 may be about 1 mm to about 10 mm, about 1 mm to about 7 mm, about 1 mm to about 5 mm, or any individual depth or range encompassed by these example depths.
In some embodiments, the fixing stencil 840 may further include stabilizing components the stencil head 841 during fixturing. For example, the stabilizing components may include a clamp positioned to hold the tapered dimple 85 or an apparatus that substantially fills the remainder of the conduit. In certain embodiments, the stencil head 841 may be capable of transmitting heat to the conduit to aid in fixturing by fusing the leaflet 801 to the conduit 80 or aiding in deformation of the conduit 80 creating a sinus bulge at the sinus when the fixing stencil 840 is removed.
Further embodiments are directed to methods for making the valved conduits described above. Such embodiments may include the steps of inverting a conduit, bending a portion of the conduit to create a tapered dimple, attaching a leaflet to the conduit on a surface surrounding the tapered dimple, and reverting the conduit placing the leaflet on an inner surface of the conduit. The step of attaching can be carried out by suturing, welding, fusing, using an adhesive, and the like or combinations thereof. In some embodiments, the method may further include the step of deforming the conduit to produce a sinus bulge. In some embodiments, bending can be carried out using a fixing stencil configured to hold conduit in a bent form creating a tapered dimple. The fixing stencil may have substantially the same shape as the tapered dimple. In various embodiments, the fixing stencil may have one or more of the parts described above.
In some embodiments, the method may include the step of cutting a valve structure from a biocompatible material. In certain embodiments, the step of cutting the valve structure may be preceded by a step of marking the biocompatible material, and in some embodiments, marking may be carried out by tracing a valve structure stencil having substantially the same shape as the valve structure onto the biocompatible material. In other embodiments, the marking can be carried out using a stamp having substantially the same shape as the valve structure. In still other embodiments, step of cutting can be carried out using a die cutting machine.
In some embodiment, the method may further include the step of marking an inner surface of the conduit with a location form attaching the leaflet to the conduit, thereby providing proper placement and alignment of the leaflets. Marking can be carried out by various means. For example, in some embodiments, marking can be carried out using a sinus stencil may be provided, and the marking on the inner surface of the conduit can be substantially the same as the sinus stencil. In such embodiments, the sinus stencil may have a shape and dimension for showing the location of the tapered dimple on the unbent inner surface of the conduit. Therefore, the sinus stencil may be wider than the valve structure, but the markings may have essentially the same shape as the leaflet after the conduit is bent.
This application claims priority from U.S. Provisional No. 62/181,521, entitled “Valved Conduit and Method for Fabricating Same,” filed Jun. 18, 2015, the entirety of which is hereby incorporated by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US16/38302 | 6/20/2016 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62181521 | Jun 2015 | US |